In recent studies our lab demonstrated the novel use of nuclear hormone receptor 2 family e, member 3 (Nr2e3) as a genetic modifier and therapeutic for several forms of RP in multiple mouse models including rd716. The gene discussed is NR2E3; the disease is retinitis pigmentosa 1.